When to Order Imaging for Diffuse Lung Disease: ACR Appropriateness Decoded

When to Order Imaging for Diffuse Lung Disease: ACR Appropriateness Decoded

It’s late in your shift, and you’re evaluating a patient with weeks of progressive dyspnea and a non-productive cough. Auscultation reveals fine bibasilar crackles. You suspect a diffuse lung disease, but the differential is broad, spanning from idiopathic pulmonary fibrosis to hypersensitivity pneumonitis. The immediate question is what imaging to order. Do you start with a chest radiograph, or is this a case that warrants going directly to a high-resolution computed tomography (CT) scan? Making the right initial choice is critical for diagnosis, avoiding unnecessary radiation, and guiding subsequent management. This article breaks down the American College of Radiology (ACR) Appropriateness Criteria for diffuse lung disease to clarify the evidence-based imaging pathways for this common clinical challenge.

What Does ACR Diffuse Lung Disease Cover?

The ACR Appropriateness Criteria for Diffuse Lung Disease provide guidance for imaging patients with suspected or known diffuse parenchymal lung disease, often referred to as interstitial lung disease (ILD). This category encompasses a large, heterogeneous group of disorders characterized by widespread inflammation and/or fibrosis of the lung parenchyma. The guidelines are designed to address common clinical scenarios encountered by primary care physicians, hospitalists, emergency physicians, and pulmonologists.

This topic specifically applies to:

• Initial diagnostic imaging for a patient with clinical suspicion of diffuse lung disease.
• Evaluation of a patient with a confirmed diagnosis who presents with acute clinical deterioration.
• Routine follow-up imaging for a stable patient with known diffuse lung disease when clinically indicated.

These criteria do not apply to other thoracic conditions such as suspected pulmonary embolism, focal consolidation concerning for pneumonia, solitary pulmonary nodule workup, or lung cancer screening. For those indications, refer to the specific ACR guidelines for each topic.

What Imaging Should I Order for Diffuse Lung Disease? Recommendations by Clinical Scenario

The optimal imaging strategy for diffuse lung disease depends entirely on the clinical context, balancing diagnostic yield with radiation exposure. The ACR provides clear recommendations for three distinct scenarios.

For a patient with suspected diffuse lung disease undergoing initial imaging, both a standard chest radiograph and a CT of the chest without IV contrast are rated as Usually Appropriate. Radiography is the logical first step due to its low radiation dose and wide availability, often providing crucial initial information. If the radiograph is inconclusive or if there is a high clinical suspicion for ILD, a non-contrast chest CT is the definitive next step for characterizing parenchymal abnormalities. A CT chest with IV contrast is rated May be Appropriate if there is a concurrent suspicion for conditions like malignancy or thromboembolic disease.

In the second scenario—a patient with confirmed diffuse lung disease and suspected acute exacerbation or deterioration—the recommendations are identical. A chest radiograph is Usually Appropriate to quickly assess for complications like pneumothorax, large effusion, or superimposed infection. A CT chest without IV contrast is also Usually Appropriate to evaluate for subtle interval changes or complications not visible on radiography. Again, a CT with IV contrast May be Appropriate if complications such as pulmonary embolism are part of the differential for the acute decline.

For the third scenario, confirmed diffuse lung disease without acute clinical deterioration requiring routine follow-up, the guidance shifts. A CT of the chest without IV contrast is the primary modality and is rated Usually Appropriate for assessing disease progression or stability. In this non-acute setting, a chest radiograph is rated May be Appropriate (Disagreement), reflecting variability in practice and its lower sensitivity for subtle fibrotic changes compared to CT. A CT Chest Without Contrast is the standard for monitoring.

ACR Imaging Recommendations Table

Adult vs. Pediatric Diffuse Lung Disease Imaging: Radiation Dose Tradeoffs

While diffuse lung diseases are less common in children, they present a significant diagnostic challenge when they do occur. The ACR guidelines provide specific pediatric relative radiation level (RRL) estimates, which are often in a higher category than for adults for the same CT scan. This reflects the increased radiosensitivity of developing tissues and the longer potential lifespan over which radiation-related risks can manifest.

The principle of As Low As Reasonably Achievable (ALARA) is paramount in pediatric imaging. For both initial workup and acute exacerbation, a chest radiograph (RRL ☢ <0.03 mSv) is a critical first-line tool to minimize dose. When a CT is necessary, protocols should be specifically tailored for pediatric patients to reduce radiation while maintaining diagnostic quality. The higher RRL category for pediatric CT (☢ ☢ ☢ ☢ 3-10 mSv) underscores the importance of ensuring the study is clearly indicated. For patients requiring serial imaging over many years, tracking cumulative radiation exposure becomes an important part of long-term management.

Imaging Protocol Details for Diffuse Lung Disease

Once you’ve decided on the right study, the specific imaging protocol is essential for maximizing diagnostic information. High-resolution chest CT (HRCT) technique, including thin-slice acquisition and inspiratory/expiratory views, is standard for evaluating ILD. Our protocol guides provide detailed, scannable information on technique, contrast administration, and key interpretation principles for the studies recommended in these guidelines.

• CT Chest Without Contrast
• CT Chest/Abdomen/Pelvis with IV Contrast

Tools to Help You Order the Right Study

Navigating imaging guidelines during a busy clinical day can be challenging. GigHz provides a suite of free reference tools designed to help clinicians apply evidence-based standards at the point of care, ensuring appropriate test selection and facilitating patient communication.

The ACR Appropriateness Criteria Lookup provides rapid access to the full library of ACR guidelines, covering thousands of clinical variants beyond diffuse lung disease. It’s designed for quick reference when you need to confirm the right imaging test for a specific indication.

For detailed procedural information, the Imaging Protocol Library offers concise, practical guides on how major imaging studies are performed. These can be used to understand the technical aspects of a recommended study or to ensure the correct protocol is ordered.

To help with patient counseling regarding radiation, the Radiation Dose Calculator allows you to estimate and track cumulative effective dose from various medical imaging procedures. This supports informed consent and adherence to the ALARA principle.

Why is a non-contrast CT usually preferred for evaluating diffuse lung disease?

A non-contrast high-resolution chest CT (HRCT) is the gold standard for assessing the lung parenchyma. It provides exquisite detail of the interstitium, airways, and secondary pulmonary lobules, which is essential for identifying and classifying patterns of fibrosis, inflammation, and ground-glass opacity. Intravenous contrast does not improve visualization of these parenchymal findings and can sometimes create artifacts that obscure subtle details.

When should I order a CT with contrast for a patient with diffuse lung disease?

A CT with IV contrast is rated as “May be Appropriate” when there is a specific co-existing concern that requires vascular or soft tissue assessment. This includes suspicion of pulmonary embolism as a cause for acute deterioration, concern for underlying malignancy, or evaluation of mediastinal lymphadenopathy or pleural disease that may be associated with certain ILDs like sarcoidosis or lymphoma.

Is a chest X-ray enough for the initial workup of suspected diffuse lung disease?

A chest X-ray is an excellent and “Usually Appropriate” first step. It is low-cost, low-radiation, and can often suggest the presence of an interstitial process, reveal an alternative diagnosis, or be entirely normal. However, a normal chest X-ray does not rule out early or subtle ILD. If clinical suspicion remains high despite a normal or non-specific radiograph, a non-contrast chest CT is the necessary next step for definitive evaluation.

Why is MRI not recommended for imaging diffuse lung disease?

Magnetic Resonance Imaging (MRI) is rated “Usually Not Appropriate” for diffuse lung disease because it has poor spatial resolution for the fine structures of the lung parenchyma compared to CT. The abundance of air-tissue interfaces in the lung leads to signal loss and artifacts on MRI, making it difficult to visualize the subtle patterns of fibrosis and inflammation characteristic of ILD. Its primary role in thoracic imaging is for specific indications like chest wall masses, certain mediastinal tumors, or cardiac evaluation.

What is the role of PET/CT in diffuse lung disease?

FDG-PET/CT is rated “Usually Not Appropriate” for the routine diagnosis and follow-up of most diffuse lung diseases. While some inflammatory ILDs, such as sarcoidosis and hypersensitivity pneumonitis, are FDG-avid, the findings are often non-specific. Its use is typically reserved for very specific clinical questions, such as assessing the extent and activity of systemic disease in sarcoidosis or investigating for an underlying malignancy in a patient with a new ILD diagnosis.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026